Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 16 Jul 2026. The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of A…
Opportunity overview
- Project name
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)?
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 16 Jul 2026. The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of A…
Who is funding Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)?
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)?
The application deadline is 16 Jul 2026 00:00 (UTC).
Where will the Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.